Oramed Pharmaceuticals (ORMP) vs Yarrow Bioscience (YARW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Oramed Pharmaceuticals (ORMP) has outperformed Yarrow Bioscience (YARW) over the past year, gaining 76.2% versus a loss of 7.6%. Over five years, ORMP leads with a -80.2% price change compared with -98.2% for YARW. Yarrow Bioscience is the larger company by market cap ($184.9 million vs $174.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ORMP | YARW |
|---|---|---|
| Share price | $4.20 | $19.87 |
| Market cap | $174.71M | $184.88M |
| 1-day change | -3.89% | +5.83% |
| YTD return | +53.33% | -31.48% |
| 1-year return | +76.21% | -7.58% |
| 5-year return | -80.19% | -98.19% |
| P/E ratio (TTM) | 1.02 | — |
| EPS (TTM) | $4.13 | — |
| Dividend yield | 5.71% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.47 | $46.95 |
| 52-week low | $2.09 | $16.05 |
| Distance from 52-week high | -23.22% | -57.68% |
| Analyst consensus | none | none |
| Avg. price target upside | +66.67% | +186.86% |
| Average volume | 192.76K | 87.51K |
| Shares outstanding | 41.60M | 9.30M |
| Employees | — | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ORMP has outperformed YARW by 83.8 percentage points over the past year.
- Oramed Pharmaceuticals offers a meaningfully higher dividend yield (5.71% vs 0.00%).
About Oramed Pharmaceuticals
ORMP stock →Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
Health Care · Biotechnology: Pharmaceutical Preparations
About Yarrow Bioscience
YARW stock →Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
ORMP vs YARW FAQ
Which is bigger, Oramed Pharmaceuticals or Yarrow Bioscience?
Yarrow Bioscience (YARW) is larger, with a market capitalization of $184.88M compared with $174.71M for Oramed Pharmaceuticals (ORMP).
Which stock has performed better over the past year, ORMP or YARW?
ORMP returned +76.21% over the past 12 months, compared with -7.58% for YARW (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Oramed Pharmaceuticals or Yarrow Bioscience?
Oramed Pharmaceuticals pays a dividend yielding 5.71%, while Yarrow Bioscience does not currently pay a regular dividend.
Are Oramed Pharmaceuticals and Yarrow Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.